APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mental Illness Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mental Illness Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchMental Illness Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mental Illness Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Mental Illness Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mental Illness Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Mental Illness Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Mental Illness Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mental Illness Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mental Illness Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mental Illness Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mental Illness Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mental Illness Drugs include Johnson and Johnson, Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mental Illness Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mental Illness Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mental Illness Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mental Illness Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Mental Illness Drugs Segment by Company

Johnson and Johnson

Eli Lilly

Pfizer

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Mental Illness Drugs Segment by Type

Substance abuse treatments

Stimulants

Sleep disorder treatments

Cognitive disorders and dementia

Antidepressants

Antipsychotics

Antianxiety (anxiolyitcs)

Anti-seizure medications

Mental Illness Drugs Segment by Application

Drugstore

Hospital

Clinic

Mental Illness Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mental Illness Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mental Illness Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mental Illness Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mental Illness Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mental Illness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mental Illness Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mental Illness Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mental Illness Drugs Industry Trends Table 2. Mental Illness Drugs Industry Drivers Table 3. Mental Illness Drugs Industry Opportunities and Challenges Table 4. Mental Illness Drugs Industry Restraints Table 5. Global Mental Illness Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mental Illness Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mental Illness Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Mental Illness Drugs Sales Market Share by Manufacturers Table 9. Global Mental Illness Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Mental Illness Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mental Illness Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mental Illness Drugs Manufacturers, Product Type & Application Table 13. Global Mental Illness Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mental Illness Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Substance abuse treatments Table 17. Major Manufacturers of Stimulants Table 18. Major Manufacturers of Sleep disorder treatments Table 19. Major Manufacturers of Cognitive disorders and dementia Table 20. Major Manufacturers of Antidepressants Table 21. Major Manufacturers of Antipsychotics Table 22. Major Manufacturers of Antianxiety (anxiolyitcs) Table 23. Major Manufacturers of Anti-seizure medications Table 24. Global Mental Illness Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 26. Global Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 27. Global Mental Illness Drugs Sales Market Share by Type (2021-2026) Table 28. Global Mental Illness Drugs Sales Market Share by Type (2027-2032) Table 29. Global Mental Illness Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 30. Global Mental Illness Drugs Revenue by Type (2021-2026) & (k units) Table 31. Global Mental Illness Drugs Revenue by Type (2027-2032) & (k units) Table 32. Global Mental Illness Drugs Revenue Market Share by Type (2021-2026) Table 33. Global Mental Illness Drugs Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Drugstore Table 35. Major Manufacturers of Hospital Table 36. Major Manufacturers of Clinic Table 37. Global Mental Illness Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 39. Global Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 40. Global Mental Illness Drugs Sales Market Share by Application (2021-2026) Table 41. Global Mental Illness Drugs Sales Market Share by Application (2027-2032) Table 42. Global Mental Illness Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global Mental Illness Drugs Revenue by Application (2021-2026) & (k units) Table 44. Global Mental Illness Drugs Revenue by Application (2027-2032) & (k units) Table 45. Global Mental Illness Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Mental Illness Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Mental Illness Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Mental Illness Drugs Sales by Region (2021-2026) & (k units) Table 49. Global Mental Illness Drugs Sales Market Share by Region (2021-2026) Table 50. Global Mental Illness Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global Mental Illness Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 54. North America Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 55. Europe Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 57. Europe Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 64. Global Mental Illness Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Mental Illness Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Mental Illness Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Mental Illness Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Mental Illness Drugs Revenue Market Share by Region (2027-2032) Table 69. Johnson and Johnson Company Information Table 70. Johnson and Johnson Business Overview Table 71. Johnson and Johnson Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson and Johnson Mental Illness Drugs Product Portfolio Table 73. Johnson and Johnson Recent Development Table 74. Eli Lilly Company Information Table 75. Eli Lilly Business Overview Table 76. Eli Lilly Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Eli Lilly Mental Illness Drugs Product Portfolio Table 78. Eli Lilly Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Mental Illness Drugs Product Portfolio Table 83. Pfizer Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Mental Illness Drugs Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. AstraZeneca Company Information Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. AstraZeneca Mental Illness Drugs Product Portfolio Table 93. AstraZeneca Recent Development Table 94. Bristol-Myers Squibb Company Information Table 95. Bristol-Myers Squibb Business Overview Table 96. Bristol-Myers Squibb Mental Illness Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Bristol-Myers Squibb Mental Illness Drugs Product Portfolio Table 98. Bristol-Myers Squibb Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Mental Illness Drugs Distributors List Table 102. Mental Illness Drugs Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Mental Illness Drugs Product Image Figure 2. Global Mental Illness Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mental Illness Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Mental Illness Drugs Sales (2021-2032) & (k units) Figure 5. Global Mental Illness Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mental Illness Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Substance abuse treatments Image Figure 9. Stimulants Image Figure 10. Sleep disorder treatments Image Figure 11. Cognitive disorders and dementia Image Figure 12. Antidepressants Image Figure 13. Antipsychotics Image Figure 14. Antianxiety (anxiolyitcs) Image Figure 15. Anti-seizure medications Image Figure 16. Global Mental Illness Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Mental Illness Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Mental Illness Drugs Sales Market Share by Type (2021-2032) Figure 19. Global Mental Illness Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Mental Illness Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Mental Illness Drugs Revenue Market Share by Type (2021-2032) Figure 22. Drugstore Image Figure 23. Hospital Image Figure 24. Clinic Image Figure 25. Global Mental Illness Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Mental Illness Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Mental Illness Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Mental Illness Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Mental Illness Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Mental Illness Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America Mental Illness Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe Mental Illness Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. France Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific Mental Illness Drugs Sales Market Share by Country (2021-2032) Figure 45. China Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. India Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa Mental Illness Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile Mental Illness Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global Mental Illness Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Mental Illness Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Mental Illness Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Mental Illness Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Substance abuse treatments
  • Stimulants
  • Sleep disorder treatments
  • Cognitive disorders and dementia
  • Antidepressants
  • Antipsychotics
  • Antianxiety (anxiolyitcs)
  • Anti-seizure medications
Applications
  • Drugstore
  • Hospital
  • Clinic
Companies covered
  • Johnson and Johnson
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mental Illness Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mental Illness Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mental Illness Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mental Illness Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mental Illness Drugs Market Dynamics
  1. 2.1 Mental Illness Drugs Industry Trends
  2. 2.2 Mental Illness Drugs Industry Drivers
  3. 2.3 Mental Illness Drugs Industry Opportunities and Challenges
  4. 2.4 Mental Illness Drugs Industry Restraints
3 Mental Illness Drugs Market by Manufacturers
  1. 3.1 Global Mental Illness Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mental Illness Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mental Illness Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mental Illness Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mental Illness Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mental Illness Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Mental Illness Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mental Illness Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mental Illness Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mental Illness Drugs Tier 1, Tier 2, and Tier 3
4 Mental Illness Drugs Market by Type
  1. 4.1 Mental Illness Drugs Type Introduction
  2. 4.1.1 Substance abuse treatments
  3. 4.1.2 Stimulants
  4. 4.1.3 Sleep disorder treatments
  5. 4.1.4 Cognitive disorders and dementia
  6. 4.1.5 Antidepressants
  7. 4.1.6 Antipsychotics
  8. 4.1.7 Antianxiety (anxiolyitcs)
  9. 4.1.8 Anti-seizure medications
  10. 4.2 Global Mental Illness Drugs Sales by Type
  11. 4.2.1 Global Mental Illness Drugs Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Mental Illness Drugs Sales by Type (2021-2032)
  13. 4.2.3 Global Mental Illness Drugs Sales Market Share by Type (2021-2032)
  14. 4.3 Global Mental Illness Drugs Revenue by Type
  15. 4.3.1 Global Mental Illness Drugs Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Mental Illness Drugs Revenue by Type (2021-2032)
  17. 4.3.3 Global Mental Illness Drugs Revenue Market Share by Type (2021-2032)
5 Mental Illness Drugs Market by Application
  1. 5.1 Mental Illness Drugs Application Introduction
  2. 5.1.1 Drugstore
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Mental Illness Drugs Sales by Application
  6. 5.2.1 Global Mental Illness Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mental Illness Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Mental Illness Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Mental Illness Drugs Revenue by Application
  10. 5.3.1 Global Mental Illness Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mental Illness Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Mental Illness Drugs Revenue Market Share by Application (2021-2032)
6 Global Mental Illness Drugs Sales by Region
  1. 6.1 Global Mental Illness Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mental Illness Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Mental Illness Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Mental Illness Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mental Illness Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mental Illness Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mental Illness Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mental Illness Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mental Illness Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mental Illness Drugs Revenue by Region
  1. 7.1 Global Mental Illness Drugs Revenue by Region
  2. 7.1.1 Global Mental Illness Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mental Illness Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Mental Illness Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Mental Illness Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mental Illness Drugs Revenue (2021-2032)
  8. 7.2.2 North America Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mental Illness Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mental Illness Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mental Illness Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mental Illness Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson and Johnson
  2. 8.1.1 Johnson and Johnson Company Information
  3. 8.1.2 Johnson and Johnson Business Overview
  4. 8.1.3 Johnson and Johnson Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio
  6. 8.1.5 Johnson and Johnson Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Mental Illness Drugs Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Mental Illness Drugs Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Mental Illness Drugs Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mental Illness Drugs Value Chain Analysis
  2. 9.1.1 Mental Illness Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mental Illness Drugs Production Mode & Process
  6. 9.2 Mental Illness Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mental Illness Drugs Distributors
  9. 9.2.3 Mental Illness Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst